Back to search

Ferndale Pharmaceuticals Limited

04720051

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)

Details

UNIT 740 STREET 2, WETHERBY, LS23 7FX
Incorporated 02/04/2003

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 08/04/2026

Due 22/04/2027

On track

Industry

20420
Manufacture of perfumes and toilet preparations
21200
Manufacture of pharmaceutical preparations

Officers

Roisin Wood

secretary · Since 15/07/2003

BRITISH

Mr Roger Mark Bloxham

director · Since 15/07/2003

MANAGING DIRECTOR

BRITISH · ENGLAND · Age 62

Mr James Thayer Mcmillan Ii

director · Since 09/09/2003

CHAIRMAN & DIRECTOR

AMERICAN · UNITED STATES · Age 80

Mr Sem Lloyd Davies

director · Since 25/05/2011

INTERNATIONAL DIRECTOR

BRITISH · UNITED KINGDOM · Age 61

Mr Christopher Stein

director · Since 03/03/2019

PRESIDENT & CHIEF OPERATING OFFICER

AMERICAN · UNITED STATES · Age 57

Persons with Significant Control

Mr Roger Mark Bloxham

25–50% shares

British · England · Age 62

Unit 740, Street 2, Wetherby, LS23 7FX

Notified 06/04/2016

Ferndale Pharma Group Inc

50–75% shares

780, West Eight Mile Road, Ferndale, 48220

Reg: 4332218 · Michigan · Incorporation

Notified 06/04/2016

CompanyRankvs 55+ SIC 20420 peers
71

Financial strength65th percentile among SIC peers · 16/25
Employees98th percentile among SIC peers · 15/15
LiquidityCurrent ratio 5.79× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength16/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

true and fair view. The financial statements have been prepared under the historical cost convention. The functional and presentational currency of the company is considered to be pounds sterling. Going Concern The financial statements have been prepared on a going concern basis. The directors have assessed the company’s ability to continue as a going concern and are satisfied that the company has

Key FinancialsYear ending 31/12/2025

Net Worth

£1k

Balance sheet strength

Cash

£2.4M

Cash in the bank

Net Current Assets

£4.0M

Working capital

Current Assets

£4.8M

Current Liabilities

£835k

Fixed Assets

£3k

Debtors

£901k

26avg. employees

Balance Sheet

Intangible assets£3k
Assets less current liabilities£4.0M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20255.79

Derived from filed accounts. Not audited figures.